# Official Journal L 322/2011

| | ISSN 1977-0677
  doi:10.3000/19770677.L_2011.322.eng |
| --- | --- |
| Official Journal
  of the European Union | L 322 |
| | |
| English edition | Legislation | Volume 546 December 2011 |

ISSN 1977-0677

doi:10.3000/19770677.L_2011.322.eng

Official Journal

of the European Union

L 322

English edition

Legislation

Volume 546 December 2011

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | * | Commission Implementing Regulation (EU) No 1262/2011 of 5 December 2011 amending Annex V to Council Regulation (EC) No 1342/2007 as regards the quantitative limits of certain steel products from the Russian Federation | 1 |
| | * | Commission Implementing Regulation (EU) No 1263/2011 of 5 December 2011 concerning the authorisation of Lactobacillus buchneri (DSM 16774), Lactobacillus buchneri (DSM 12856), Lactobacillus paracasei (DSM 16245), Lactobacillus paracasei (DSM 16773), Lactobacillus plantarum (DSM 12836), Lactobacillus plantarum (DSM 12837), Lactobacillus brevis (DSM 12835), Lactobacillus rhamnosus (NCIMB 30121), Lactococcus lactis (DSM 11037), Lactococcus lactis (NCIMB 30160), Pediococcus acidilactici (DSM 16243) and Pediococcus pentosaceus (DSM 12834) as feed additives for all animal species (
  1
  ) | 3 |
| | | Commission Implementing Regulation (EU) No 1264/2011 of 5 December 2011 establishing the standard import values for determining the entry price of certain fruit and vegetables | 9 |
| | | DECISIONS |
| | | 2011/807/EU |
| | * | Commission Implementing Decision of 30 November 2011 approving annual and multiannual programmes and the financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2012 and following years
  (notified under document C(2011) 8719) | 11 |

Contents

II   Non-legislative acts

page

REGULATIONS

*

Commission Implementing Regulation (EU) No 1262/2011 of 5 December 2011 amending Annex V to Council Regulation (EC) No 1342/2007 as regards the quantitative limits of certain steel products from the Russian Federation

1

*

Commission Implementing Regulation (EU) No 1263/2011 of 5 December 2011 concerning the authorisation of Lactobacillus buchneri (DSM 16774), Lactobacillus buchneri (DSM 12856), Lactobacillus paracasei (DSM 16245), Lactobacillus paracasei (DSM 16773), Lactobacillus plantarum (DSM 12836), Lactobacillus plantarum (DSM 12837), Lactobacillus brevis (DSM 12835), Lactobacillus rhamnosus (NCIMB 30121), Lactococcus lactis (DSM 11037), Lactococcus lactis (NCIMB 30160), Pediococcus acidilactici (DSM 16243) and Pediococcus pentosaceus (DSM 12834) as feed additives for all animal species (
  1
  )

Lactobacillus buchneri

Lactobacillus buchneri

Lactobacillus paracasei

Lactobacillus paracasei

Lactobacillus plantarum

Lactobacillus plantarum

Lactobacillus brevis

Lactobacillus rhamnosus

Lactococcus lactis

Lactococcus lactis

Pediococcus acidilactici

Pediococcus pentosaceus

1

3

Commission Implementing Regulation (EU) No 1264/2011 of 5 December 2011 establishing the standard import values for determining the entry price of certain fruit and vegetables

9

DECISIONS

2011/807/EU

*

Commission Implementing Decision of 30 November 2011 approving annual and multiannual programmes and the financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2012 and following years
  (notified under document C(2011) 8719)

(notified under document C(2011) 8719)

11

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.

---

II Non-legislative acts

REGULATIONS

| 6.12.2011 | EN | Official Journal of the European Union | L 322/1 |
| --- | --- | --- | --- |

6.12.2011

EN

Official Journal of the European Union

L 322/1

---

COMMISSION IMPLEMENTING REGULATION (EU) No 1262/2011

of 5 December 2011

amending Annex V to Council Regulation (EC) No 1342/2007 as regards the quantitative limits of certain steel products from the Russian Federation

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Regulation (EC) No 1342/2007 of 22 October 2007 on administering certain restrictions on imports of certain steel products from the Russian Federation (1), and in particular Article 5 thereof,

Whereas:

| (1) | The European Community and the Russian Federation signed an agreement on trade in certain steel products on 26 October 2007 (2) (the Agreement). |
| --- | --- |

(1)

The European Community and the Russian Federation signed an agreement on trade in certain steel products on 26 October 2007 (2) (the Agreement).

| (2) | Article 3(3) of the Agreement provides that unused quantities for a given year may be carried over to the following year up to a maximum of 7 % of the relevant quantitative limit set out in Annex II to the Agreement. |
| --- | --- |

(2)

Article 3(3) of the Agreement provides that unused quantities for a given year may be carried over to the following year up to a maximum of 7 % of the relevant quantitative limit set out in Annex II to the Agreement.

| (3) | Pursuant to Article 3(4) of the Agreement transfers between product groups may be made up to 7 % of the quantitative limit of a given product group. |
| --- | --- |

(3)

Pursuant to Article 3(4) of the Agreement transfers between product groups may be made up to 7 % of the quantitative limit of a given product group.

| (4) | Russia has notified the European Union of its intent to make use of the provisions in Article 3(3) and (4) within the time limits set by the Agreement. It is appropriate to make the necessary adjustments to the quantitative limits for the year 2011 resulting from Russia’s request. |
| --- | --- |

(4)

Russia has notified the European Union of its intent to make use of the provisions in Article 3(3) and (4) within the time limits set by the Agreement. It is appropriate to make the necessary adjustments to the quantitative limits for the year 2011 resulting from Russia’s request.

| (5) | Article 10 of the Agreement stipulates that with each yearly renewal, quantities in every product group shall be increased by 2,5 %. |
| --- | --- |

(5)

Article 10 of the Agreement stipulates that with each yearly renewal, quantities in every product group shall be increased by 2,5 %.

| (6) | Regulation (EC) No 1342/2007 should be amended accordingly, |
| --- | --- |

(6)

Regulation (EC) No 1342/2007 should be amended accordingly,

HAS ADOPTED THIS REGULATION:

Article 1

Annex V to Regulation (EC) No 1342/2007 is replaced by the text set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the day following its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 5 December 2011.

For the Commission

The President

José Manuel BARROSO

---

(1)  
  OJ L 300, 17.11.2007, p. 1.

1

(2)  
  OJ L 300, 17.11.2007, p. 52.

2

---

ANNEX

‘ANNEX V

QUANTITATIVE LIMITS

| (tonnes) |
| --- |
| Products | Year 2011 | Year 2012 |
| SA. Flat products |
| SA1. Coils | 1 230 897 | 1 142 446 |
| SA2. Heavy plate | 297 127 | 303 549 |
| SA3. Other flat products | 676 140 | 656 769 |
| SA4. Alloyed products | 113 444 | 115 900 |
| SA5. Alloyed quarto plates | 27 011 | 27 595 |
| SA6. Alloyed cold-rolled and coated sheets | 121 096 | 121 419 |
| SB. Long products |
| SB1. Beams | 63 570 | 60 710 |
| SB2. Wire rod | 374 481 | 357 635 |
| SB3. Other long products | 586 180 | 559 633 |
| Note | : | SA and SB are product categories
  SA1 to SA6 and SB1 to SB3 are product groups.’ |

(tonnes)

Products

Year 2011

Year 2012

SA. Flat products

SA1. Coils

1 230 897

1 142 446

SA2. Heavy plate

297 127

303 549

SA3. Other flat products

676 140

656 769

SA4. Alloyed products

113 444

115 900

SA5. Alloyed quarto plates

27 011

27 595

SA6. Alloyed cold-rolled and coated sheets

121 096

121 419

SB. Long products

SB1. Beams

63 570

60 710

SB2. Wire rod

374 481

357 635

SB3. Other long products

586 180

559 633

Note

:

SA and SB are product categories

SA1 to SA6 and SB1 to SB3 are product groups.’

---

| 6.12.2011 | EN | Official Journal of the European Union | L 322/3 |
| --- | --- | --- | --- |

6.12.2011

EN

Official Journal of the European Union

L 322/3

---

COMMISSION IMPLEMENTING REGULATION (EU) No 1263/2011

of 5 December 2011

concerning the authorisation of Lactobacillus buchneri (DSM 16774), Lactobacillus buchneri (DSM 12856), Lactobacillus paracasei (DSM 16245), Lactobacillus paracasei (DSM 16773), Lactobacillus plantarum (DSM 12836), Lactobacillus plantarum (DSM 12837), Lactobacillus brevis (DSM 12835), Lactobacillus rhamnosus (NCIMB 30121), Lactococcus lactis (DSM 11037), Lactococcus lactis (NCIMB 30160), Pediococcus acidilactici (DSM 16243) and Pediococcus pentosaceus (DSM 12834) as feed additives for all animal species

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition (1), and in particular Article 9(2) thereof,

Whereas:

| (1) | Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting such authorisation. |
| --- | --- |

(1)

Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting such authorisation.

| (2) | In accordance with Article 7 of Regulation (EC) No 1831/2003, applications were submitted for the authorisation of Lactobacillus buchneri (DSM 16774), Lactobacillus buchneri (DSM 12856), Lactobacillus paracasei (DSM 16245), Lactobacillus paracasei (DSM 16773), Lactobacillus plantarum (DSM 12836), Lactobacillus plantarum (DSM 12837), Lactobacillus brevis (DSM 12835), Lactobacillus rhamnosus (NCIMB 30121), Lactococcus lactis (DSM 11037), Lactococcus lactis (NCIMB 30160), Pediococcus acidilactici (DSM 16243) and Pediococcus pentosaceus (DSM 12834). Those applications were accompanied by the particulars and documents required under Article 7(3) of Regulation (EC) No 1831/2003. |
| --- | --- |

(2)

In accordance with Article 7 of Regulation (EC) No 1831/2003, applications were submitted for the authorisation of Lactobacillus buchneri (DSM 16774), Lactobacillus buchneri (DSM 12856), Lactobacillus paracasei (DSM 16245), Lactobacillus paracasei (DSM 16773), Lactobacillus plantarum (DSM 12836), Lactobacillus plantarum (DSM 12837), Lactobacillus brevis (DSM 12835), Lactobacillus rhamnosus (NCIMB 30121), Lactococcus lactis (DSM 11037), Lactococcus lactis (NCIMB 30160), Pediococcus acidilactici (DSM 16243) and Pediococcus pentosaceus (DSM 12834). Those applications were accompanied by the particulars and documents required under Article 7(3) of Regulation (EC) No 1831/2003.

| (3) | The applications concern the authorisation of Lactobacillus buchneri (DSM 16774), Lactobacillus buchneri (DSM 12856), Lactobacillus paracasei (DSM 16245), Lactobacillus paracasei (DSM 16773), Lactobacillus plantarum (DSM 12836), Lactobacillus plantarum (DSM 12837), Lactobacillus brevis (DSM 12835), Lactobacillus rhamnosus (NCIMB 30121), Lactococcus lactis (DSM 11037) Lactococcus lactis (NCIMB 30160), Pediococcus acidilactici (DSM 16243) and Pediococcus pentosaceus (DSM 12834) as feed additives for all animal species, to be classified in the additive category ‘technological additives’. |
| --- | --- |

(3)

The applications concern the authorisation of Lactobacillus buchneri (DSM 16774), Lactobacillus buchneri (DSM 12856), Lactobacillus paracasei (DSM 16245), Lactobacillus paracasei (DSM 16773), Lactobacillus plantarum (DSM 12836), Lactobacillus plantarum (DSM 12837), Lactobacillus brevis (DSM 12835), Lactobacillus rhamnosus (NCIMB 30121), Lactococcus lactis (DSM 11037) Lactococcus lactis (NCIMB 30160), Pediococcus acidilactici (DSM 16243) and Pediococcus pentosaceus (DSM 12834) as feed additives for all animal species, to be classified in the additive category ‘technological additives’.

| (4) | The European Food Safety Authority (the Authority) concluded in its opinions of 6 September 2011 on Lactobacillus buchneri (DSM 16774) (2), Lactobacillus buchneri (DSM 12856) (3) and on Lactobacillus brevis (DSM 12835) (4), that these micro-organisms do not have an adverse effect on animal health, human health or the environment, and that they have the potential to improve the production of silage from all forages by increasing acetic production resulting in an extended aerobic stability of the silage. The Authority does not consider that there is a need for specific requirements of post-market monitoring. It also verified the report on the method of analysis of the feed additives in feed submitted by the Community Reference Laboratory set up by Regulation (EC) No 1831/2003. |
| --- | --- |

(4)

The European Food Safety Authority (the Authority) concluded in its opinions of 6 September 2011 on Lactobacillus buchneri (DSM 16774) (2), Lactobacillus buchneri (DSM 12856) (3) and on Lactobacillus brevis (DSM 12835) (4), that these micro-organisms do not have an adverse effect on animal health, human health or the environment, and that they have the potential to improve the production of silage from all forages by increasing acetic production resulting in an extended aerobic stability of the silage. The Authority does not consider that there is a need for specific requirements of post-market monitoring. It also verified the report on the method of analysis of the feed additives in feed submitted by the Community Reference Laboratory set up by Regulation (EC) No 1831/2003.

| (5) | The Authority concluded in its opinions of 6 September 2011 on Lactobacillus paracasei (DSM 16245) (5), on Lactobacillus paracasei (DSM 16773) (6), Lactobacillus plantarum (DSM 12836) (7)
  Lactobacillus plantarum (DSM 12837) (8), Lactobacillus rhamnosus (NCIMB 30121) (9)
  Lactococcus lactis (NCIMB 30160) (10)
  Pediococcus acidilactici (DSM 16243) (11) and on Pediococcus pentosaceus (DSM 12834) (12), and in its opinion of 8 September 2011 on Lactococcus lactis (DSM 11037) (13) that these micro-organisms do not have an adverse effect on animal health, human health or the environment, and that they have the potential to improve the production of silage from all forages by reducing the pH and increasing the preservation of the dry matter. The Authority does not consider that there is a need for specific requirements of post-market monitoring. It also verified the report on the method of analysis of the feed additives in feed submitted by the Community Reference Laboratory set up by Regulation (EC) No 1831/2003. |
| --- | --- |

(5)

The Authority concluded in its opinions of 6 September 2011 on Lactobacillus paracasei (DSM 16245) (5), on Lactobacillus paracasei (DSM 16773) (6), Lactobacillus plantarum (DSM 12836) (7)
  Lactobacillus plantarum (DSM 12837) (8), Lactobacillus rhamnosus (NCIMB 30121) (9)
  Lactococcus lactis (NCIMB 30160) (10)
  Pediococcus acidilactici (DSM 16243) (11) and on Pediococcus pentosaceus (DSM 12834) (12), and in its opinion of 8 September 2011 on Lactococcus lactis (DSM 11037) (13) that these micro-organisms do not have an adverse effect on animal health, human health or the environment, and that they have the potential to improve the production of silage from all forages by reducing the pH and increasing the preservation of the dry matter. The Authority does not consider that there is a need for specific requirements of post-market monitoring. It also verified the report on the method of analysis of the feed additives in feed submitted by the Community Reference Laboratory set up by Regulation (EC) No 1831/2003.

| (6) | The assessment of Lactobacillus buchneri (DSM 16774), Lactobacillus buchneri (DSM 12856), Lactobacillus paracasei (DSM 16245), Lactobacillus paracasei (DSM 16773),Lactobacillus plantarum (DSM 12836), Lactobacillus plantarum (DSM 12837), Lactobacillus brevis (DSM 12835), Lactobacillus rhamnosus (NCIMB 30121), Lactococcus lactis (DSM 11037), Lactococcus lactis (NCIMB 30160), Pediococcus acidilactici (DSM 16243) and Pediococcus pentosaceus (DSM 12834) shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied. Accordingly, the use of those micro-organisms should be authorised as specified in the Annex to this Regulation. |
| --- | --- |

(6)

The assessment of Lactobacillus buchneri (DSM 16774), Lactobacillus buchneri (DSM 12856), Lactobacillus paracasei (DSM 16245), Lactobacillus paracasei (DSM 16773),Lactobacillus plantarum (DSM 12836), Lactobacillus plantarum (DSM 12837), Lactobacillus brevis (DSM 12835), Lactobacillus rhamnosus (NCIMB 30121), Lactococcus lactis (DSM 11037), Lactococcus lactis (NCIMB 30160), Pediococcus acidilactici (DSM 16243) and Pediococcus pentosaceus (DSM 12834) shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied. Accordingly, the use of those micro-organisms should be authorised as specified in the Annex to this Regulation.

| (7) | The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health, |
| --- | --- |

(7)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS REGULATION:

Article 1

The micro-organisms specified in the Annex belonging to the additive category ‘technological additives’ and to the functional group ‘silage additives’, are authorised as additives in animal nutrition subject to the conditions laid down in that Annex.

Article 2

This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union.

This Regulation is binding in its entirety and directly applicable in all Member States.

Done at Brussels, 5 December 2011.

For the Commission

The President

José Manuel BARROSO

---

(1)  
  OJ L 268, 18.10.2003, p. 29.

1

(2)  EFSA Journal 2011; 9(9):2359.

2

(3)  EFSA Journal 2011; 9(9):2361.

3

(4)  EFSA Journal 2011; 9(9):2368.

4

(5)  EFSA Journal 2011; 9(9):2363.

5

(6)  EFSA Journal 2011; 9(9):2370.

6

(7)  EFSA Journal 2011; 9(9):2367.

7

(8)  EFSA Journal 2011; 9(9):2362.

8

(9)  EFSA Journal 2011; 9(9):2365.

9

(10)  EFSA Journal 2011; 9(9):2366.

10

(11)  EFSA Journal 2011; 9(9):2364.

11

(12)  EFSA Journal 2011; 9(9):2369.

12

(13)  EFSA Journal 2011; 9(9):2374.

13

---

ANNEX

| Identification number of the additive | Name of the holder of authorisation | Additive | Composition, chemical formula, description, analytical method. | Species or category of animal | Maximum age | Minimum content | Maximum content | Other provisions | End of period of authorisation |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| CFU/kg of fresh material |
| Category of technological additives. Functional group: silage additives. |
| 1k2074 | — | Lactobacillus buchneri

  (DSM 16774) | | Additive composition:
  Preparation of Lactobacillus buchneri (DSM 16774) containing a minimum of 5 × 1011 CFU/g additive |

Identification number of the additive

Name of the holder of authorisation

Additive

Composition, chemical formula, description, analytical method.

Species or category of animal

Maximum age

Minimum content

Maximum content

Other provisions

End of period of authorisation

CFU/kg of fresh material

Category of technological additives. Functional group: silage additives.

1k2074

—

Lactobacillus buchneri

(DSM 16774)

Additive composition:

Preparation of Lactobacillus buchneri (DSM 16774) containing a minimum of 5 × 1011 CFU/g additive

| | Characterisation of the active substance:

  Lactobacillus buchneri (DSM 16774) |
| --- | --- |

Characterisation of the active substance:

Lactobacillus buchneri (DSM 16774)

| | Analytical method (1) | Enumeration: spread plate method using MSR agar (EN 15787) |
| --- | --- | --- |

Analytical method (1)

Enumeration: spread plate method using MSR agar (EN 15787)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

1k2075

—

Lactobacillus buchneri

(DSM 12856)

| | Additive composition:
  Preparation of Lactobacillus buchneri (DSM 12856) containing a minimum of 5 × 1011 CFU/g additive |
| --- | --- |

Additive composition:

Preparation of Lactobacillus buchneri (DSM 12856) containing a minimum of 5 × 1011 CFU/g additive

| | Characterisation of the active substance:

  Lactobacillus buchneri (DSM 12856) |
| --- | --- |

Characterisation of the active substance:

Lactobacillus buchneri (DSM 12856)

| | Analytical method (1) | Enumeration: spread plate method using MSR agar (EN 15787) |
| --- | --- | --- |

Analytical method (1)

Enumeration: spread plate method using MSR agar (EN 15787)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

1k2076

—

Lactobacillus paracasei

(DSM 16245)

| | Additive composition:
  Preparation of Lactobacillus paracasei (DSM 16245) containing a minimum of 5 × 1011 CFU/g additive |
| --- | --- |

Additive composition:

Preparation of Lactobacillus paracasei (DSM 16245) containing a minimum of 5 × 1011 CFU/g additive

| | Characterisation of the active substance:

  Lactobacillus paracasei (DSM 16245) |
| --- | --- |

Characterisation of the active substance:

Lactobacillus paracasei (DSM 16245)

| | Analytical method (1) | Enumeration: spread plate method using MSR agar (EN 15787) |
| --- | --- | --- |

Analytical method (1)

Enumeration: spread plate method using MSR agar (EN 15787)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

1k2077

—

Lactobacillus paracasei

(DSM 16773)

| | Additive composition:
  Preparation of Lactobacillus paracasei (DSM 16773) containing a minimum of 4 × 1011 CFU/g additive |
| --- | --- |

Additive composition:

Preparation of Lactobacillus paracasei (DSM 16773) containing a minimum of 4 × 1011 CFU/g additive

| | Characterisation of the active substance:

  Lactobacillus paracasei (DSM 16773) |
| --- | --- |

Characterisation of the active substance:

Lactobacillus paracasei (DSM 16773)

| | Analytical method (1) | Enumeration: spread plate method using MSR agar (EN 15787) |
| --- | --- | --- |

Analytical method (1)

Enumeration: spread plate method using MSR agar (EN 15787)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

1k2078

—

Lactobacillus plantarum

(DSM 12836)

| | Additive composition:
  Preparation of Lactobacillus plantarum (DSM 12836) containing a minimum of 5 × 1011 CFU/g additive |
| --- | --- |

Additive composition:

Preparation of Lactobacillus plantarum (DSM 12836) containing a minimum of 5 × 1011 CFU/g additive

| | Characterisation of the active substance:

  Lactobacillus plantarum (DSM 12836) |
| --- | --- |

Characterisation of the active substance:

Lactobacillus plantarum (DSM 12836)

| | Analytical method (1) | Enumeration: spread plate method using MSR agar (EN 15787) |
| --- | --- | --- |

Analytical method (1)

Enumeration: spread plate method using MSR agar (EN 15787)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

1k2079

—

Lactobacillus plantarum

(DSM 12837)

| | Additive composition:
  Preparation of Lactobacillus plantarum (DSM 12837) containing a minimum of 5 × 1011 CFU/g additive |
| --- | --- |

Additive composition:

Preparation of Lactobacillus plantarum (DSM 12837) containing a minimum of 5 × 1011 CFU/g additive

| | Characterisation of the active substance:

  Lactobacillus plantarum (DSM 12837) |
| --- | --- |

Characterisation of the active substance:

Lactobacillus plantarum (DSM 12837)

| | Analytical method (1) | Enumeration: spread plate method using MSR agar (EN 15787) |
| --- | --- | --- |

Analytical method (1)

Enumeration: spread plate method using MSR agar (EN 15787)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

1k20710

—

Lactobacillus brevis

(DSM 12835)

| | Additive composition:
  Preparation of Lactobacillus brevis (DSM 12835) containing a minimum of 5 × 1011 CFU/g additive |
| --- | --- |

Additive composition:

Preparation of Lactobacillus brevis (DSM 12835) containing a minimum of 5 × 1011 CFU/g additive

| | Characterisation of the active substance:

  Lactobacillus brevis (DSM 12835) |
| --- | --- |

Characterisation of the active substance:

Lactobacillus brevis (DSM 12835)

| | Analytical method (1) | Enumeration: spread plate method using MSR agar (EN 15787) |
| --- | --- | --- |

Analytical method (1)

Enumeration: spread plate method using MSR agar (EN 15787)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

1k20711

—

Lactobacillus rhamnosus

(NCIMB 30121)

| | Additive composition:
  Preparation of Lactobacillus rhamnosus (NCIMB 30121) containing a minimum of 4 × 1011 CFU/g additive |
| --- | --- |

Additive composition:

Preparation of Lactobacillus rhamnosus (NCIMB 30121) containing a minimum of 4 × 1011 CFU/g additive

| | Characterisation of the active substance:

  Lactobacillus rhamnosus (NCIMB 30121) |
| --- | --- |

Characterisation of the active substance:

Lactobacillus rhamnosus (NCIMB 30121)

| | Analytical method (1) | Enumeration: spread plate method using MSR agar (EN 15787) |
| --- | --- | --- |

Analytical method (1)

Enumeration: spread plate method using MSR agar (EN 15787)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

1k2081

—

Lactococcus lactis

(DSM 11037)

| | Additive composition:
  Preparation of Lactococcus lactis (DSM 11037) containing a minimum of 5 × 1010 CFU/g additive |
| --- | --- |

Additive composition:

Preparation of Lactococcus lactis (DSM 11037) containing a minimum of 5 × 1010 CFU/g additive

| | Characterisation of the active substance:

  Lactococcus lactis (DSM 11037) |
| --- | --- |

Characterisation of the active substance:

Lactococcus lactis (DSM 11037)

| | Analytical method (1) | Enumeration: pour plate method using MSR agar (ISO 15214) |
| --- | --- | --- |

Analytical method (1)

Enumeration: pour plate method using MSR agar (ISO 15214)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

1k2082

—

Lactococcus lactis

(NCIMB 30160)

| | Additive composition:
  Preparation of Lactococcus lactis (NCIMB 30160) containing a minimum of 4 × 1011 CFU/g additive |
| --- | --- |

Additive composition:

Preparation of Lactococcus lactis (NCIMB 30160) containing a minimum of 4 × 1011 CFU/g additive

| | Characterisation of the active substance:

  Lactococcus lactis (NCIMB 30160) |
| --- | --- |

Characterisation of the active substance:

Lactococcus lactis (NCIMB 30160)

| | Analytical method (1) | Enumeration: pour plate method using MSR agar (ISO 15214) |
| --- | --- | --- |

Analytical method (1)

Enumeration: pour plate method using MSR agar (ISO 15214)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/Kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/Kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

1k2102

—

Pediococcus acidilactici

(DSM 16243)

| | Additive composition:
  Preparation of Pediococcus acidilactici (DSM 16243) containing a minimum of 5 × 1011 CFU/g additive |
| --- | --- |

Additive composition:

Preparation of Pediococcus acidilactici (DSM 16243) containing a minimum of 5 × 1011 CFU/g additive

| | Characterisation of the active substance:

  Pediococcus acidilactici (DSM 16243) |
| --- | --- |

Characterisation of the active substance:

Pediococcus acidilactici (DSM 16243)

| | Analytical method (1) | Enumeration: spread plate method using MSR agar (EN 15786) |
| --- | --- | --- |

Analytical method (1)

Enumeration: spread plate method using MSR agar (EN 15786)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

1k2103

—

Pediococcus pentosaceus

(DSM 12834)

| | Additive composition:
  Preparation of Pediococcus pentosaceus (DSM 12834) containing a minimum of 4 × 1011 CFU/g additive |
| --- | --- |

Additive composition:

Preparation of Pediococcus pentosaceus (DSM 12834) containing a minimum of 4 × 1011 CFU/g additive

| | Characterisation of the active substance:

  Pediococcus pentosaceus (DSM 12834) |
| --- | --- |

Characterisation of the active substance:

Pediococcus pentosaceus (DSM 12834)

| | Analytical method (1) | Enumeration: spread plate method using MSR agar (EN 15786) |
| --- | --- | --- |

Analytical method (1)

Enumeration: spread plate method using MSR agar (EN 15786)

| | Identification: Pulsed-Field Gel Electrophoresis (PFGE). |
| --- | --- |

Identification: Pulsed-Field Gel Electrophoresis (PFGE).

All animal species

—

—

—

| 1. | In the directions for use of the additive and premixture, indicate the storage temperature and storage life. |
| --- | --- |

1.

In the directions for use of the additive and premixture, indicate the storage temperature and storage life.

| 2. | Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material. |
| --- | --- |

2.

Minimum dose of the additive when used without combination with other micro-organisms as silage additives: 1 × 108 CFU/kg fresh material.

| 3. | For safety: it is recommended to use breathing protection and gloves during handling. |
| --- | --- |

3.

For safety: it is recommended to use breathing protection and gloves during handling.

26.12.2021

---

(1)  Details of the analytical methods are available at the following address of the Reference Laboratory: http://irmm.jrc.ec.europa.eu/EURLs/EURL_feed_additives/Pages/index.aspx

---

| 6.12.2011 | EN | Official Journal of the European Union | L 322/9 |
| --- | --- | --- | --- |

6.12.2011

EN

Official Journal of the European Union

L 322/9

---

COMMISSION IMPLEMENTING REGULATION (EU) No 1264/2011

of 5 December 2011

establishing the standard import values for determining the entry price of certain fruit and vegetables

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Regulation (EC) No 1234/2007 of 22 October 2007 establishing a common organisation of agricultural markets and on specific provisions for certain agricultural products (Single CMO Regulation) (1),

Having regard to Commission Implementing Regulation (EU) No 543/2011 of 7 June 2011 laying down detailed rules for the application of Council Regulation (EC) No 1234/2007 in respect of the fruit and vegetables and processed fruit and vegetables sectors (2), and in particular Article 136(1) thereof,

Whereas:

Implementing Regulation (EU) No 543/2011 lays down, pursuant to the outcome of the Uruguay Round multilateral trade negotiations, the criteria whereby the Commission fixes the standard values for imports from third countries, in respect of the products and periods stipulated in Annex XVI, Part A thereto,

HAS ADOPTED THIS REGULATION:

Article 1

The standard import values referred to in Article 136 of Implementing Regulation (EU) No 543/2011 are fixed in the Annex hereto.

Article 2

This Regulation shall enter into force on 6 December 2011.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 5 December 2011.

For the Commission, On behalf of the President,

José Manuel SILVA RODRÍGUEZ

Director-General for Agriculture and Rural Development

---

(1)  
  OJ L 299, 16.11.2007, p. 1.

1

(2)  
  OJ L 157, 15.6.2011, p. 1.

2

---

ANNEX

Standard import values for determining the entry price of certain fruit and vegetables

| (EUR/100 kg) |
| --- |
| CN code | Third country code (1) | Standard import value |
| 0702 00 00 | AL | 58,4 |
| MA | 50,0 |
| MK | 68,6 |
| TR | 83,5 |
| ZZ | 65,1 |
| 0707 00 05 | EG | 193,3 |
| TR | 89,9 |
| ZZ | 141,6 |
| 0709 90 70 | MA | 33,8 |
| TR | 126,2 |
| ZZ | 80,0 |
| 0805 10 20 | AR | 40,6 |
| BR | 41,5 |
| MA | 56,6 |
| TR | 45,6 |
| UY | 42,5 |
| ZA | 48,9 |
| ZZ | 46,0 |
| 0805 20 10 | MA | 71,8 |
| ZZ | 71,8 |
| 0805 20 30 , 0805 20 50 , 0805 20 70 , 0805 20 90 | HR | 32,0 |
| IL | 76,9 |
| JM | 129,1 |
| TR | 74,8 |
| UY | 71,0 |
| ZZ | 76,8 |
| 0805 50 10 | TR | 62,3 |
| ZZ | 62,3 |
| 0808 10 80 | CA | 120,5 |
| CL | 90,0 |
| US | 118,6 |
| ZA | 180,1 |
| ZZ | 127,3 |
| 0808 20 50 | CN | 82,4 |
| TR | 133,1 |
| ZZ | 107,8 |

(EUR/100 kg)

CN code

Third country code (1)

Standard import value

0702 00 00

AL

58,4

MA

50,0

MK

68,6

TR

83,5

ZZ

65,1

0707 00 05

EG

193,3

TR

89,9

ZZ

141,6

0709 90 70

MA

33,8

TR

126,2

ZZ

80,0

0805 10 20

AR

40,6

BR

41,5

MA

56,6

TR

45,6

UY

42,5

ZA

48,9

ZZ

46,0

0805 20 10

MA

71,8

ZZ

71,8

0805 20 30 , 0805 20 50 , 0805 20 70 , 0805 20 90

HR

32,0

IL

76,9

JM

129,1

TR

74,8

UY

71,0

ZZ

76,8

0805 50 10

TR

62,3

ZZ

62,3

0808 10 80

CA

120,5

CL

90,0

US

118,6

ZA

180,1

ZZ

127,3

0808 20 50

CN

82,4

TR

133,1

ZZ

107,8

---

(1)  Nomenclature of countries laid down by Commission Regulation (EC) No 1833/2006 (OJ L 354, 14.12.2006, p. 19). Code ‘
  ZZ
  ’ stands for ‘of other origin’.

---

DECISIONS

| 6.12.2011 | EN | Official Journal of the European Union | L 322/11 |
| --- | --- | --- | --- |

6.12.2011

EN

Official Journal of the European Union

L 322/11

---

COMMISSION IMPLEMENTING DECISION

of 30 November 2011

approving annual and multiannual programmes and the financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2012 and following years

(notified under document C(2011) 8719)

(2011/807/EU)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Decision 2009/470/EC of 25 May 2009 on expenditure in the veterinary field (1), and in particular Article 27(5) thereof,

Whereas:

| (1) | Decision 2009/470/EC lays down the procedures governing the Union financial contribution for programmes for the eradication, control and monitoring of animal diseases and zoonoses. |
| --- | --- |

(1)

Decision 2009/470/EC lays down the procedures governing the Union financial contribution for programmes for the eradication, control and monitoring of animal diseases and zoonoses.

| (2) | In addition, Article 27(1) of Decision 2009/470/EC provides that a Union financial measure is to be introduced to reimburse the expenditure incurred by the Member States for the financing of national programmes for the eradication, control and monitoring of the animal diseases and zoonoses listed in Annex 1 to that Decision. |
| --- | --- |

(2)

In addition, Article 27(1) of Decision 2009/470/EC provides that a Union financial measure is to be introduced to reimburse the expenditure incurred by the Member States for the financing of national programmes for the eradication, control and monitoring of the animal diseases and zoonoses listed in Annex 1 to that Decision.

| (3) | Commission Decision 2008/341/EC of 25 April 2008 laying down Community criteria for national programmes for the eradication, control and monitoring of certain animal diseases and zoonoses (2) provides that in order to be approved under the Union financial measures, programmes submitted by the Member States must meet at least the criteria set out in the Annex to that Decision. |
| --- | --- |

(3)

Commission Decision 2008/341/EC of 25 April 2008 laying down Community criteria for national programmes for the eradication, control and monitoring of certain animal diseases and zoonoses (2) provides that in order to be approved under the Union financial measures, programmes submitted by the Member States must meet at least the criteria set out in the Annex to that Decision.

| (4) | Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (3) provides for annual monitoring programmes by Member States for transmissible spongiform encephalopathies (TSEs) in bovine, ovine and caprine animals. |
| --- | --- |

(4)

Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (3) provides for annual monitoring programmes by Member States for transmissible spongiform encephalopathies (TSEs) in bovine, ovine and caprine animals.

| (5) | Council Directive 2005/94/EC of 20 December 2005 on Community measures for the control of avian influenza (4) also provides for surveillance programmes by Member States to be carried out in respect of poultry and wild birds in order to contribute, inter alia, on the basis of regularly updated risk-assessments, to the knowledge on the threats posed by the wild birds in relation to any influenza virus of avian origin in birds. Those annual programmes, and their financing, for monitoring should also be approved. |
| --- | --- |

(5)

Council Directive 2005/94/EC of 20 December 2005 on Community measures for the control of avian influenza (4) also provides for surveillance programmes by Member States to be carried out in respect of poultry and wild birds in order to contribute, inter alia, on the basis of regularly updated risk-assessments, to the knowledge on the threats posed by the wild birds in relation to any influenza virus of avian origin in birds. Those annual programmes, and their financing, for monitoring should also be approved.

| (6) | Certain Member States have submitted to the Commission annual programmes for the eradication, control and monitoring of animal diseases, programmes of checks aimed at the prevention of zoonoses, and annual monitoring programmes for the eradication and monitoring of certain TSEs for which they wish to receive a financial contribution from the Union. |
| --- | --- |

(6)

Certain Member States have submitted to the Commission annual programmes for the eradication, control and monitoring of animal diseases, programmes of checks aimed at the prevention of zoonoses, and annual monitoring programmes for the eradication and monitoring of certain TSEs for which they wish to receive a financial contribution from the Union.

| (7) | For the years 2008, 2009, 2010 and 2011 certain multiannual programmes submitted by Member States for the eradication, control and monitoring of the animal diseases were approved under Commission Decisions 2007/782/EC (5), 2008/897/EC (6), 2009/883/EC (7) and 2010/712/EU (8). |
| --- | --- |

(7)

For the years 2008, 2009, 2010 and 2011 certain multiannual programmes submitted by Member States for the eradication, control and monitoring of the animal diseases were approved under Commission Decisions 2007/782/EC (5), 2008/897/EC (6), 2009/883/EC (7) and 2010/712/EU (8).

| (8) | The commitment of the expenditure for those multiannual programmes was adopted in accordance with Article 76(3) of Council Regulation (EC, Euratom) No 1605/2002 of 25 June 2002 on the Financial Regulation applicable to the general budget of the European Communities (9). The first budget commitment for those programmes was made after their approval. Each subsequent annual commitment should be made by the Commission in function of the execution of the programme for the previous year, on the basis of a decision to grant a contribution referred to in Article 27(5) of Decision 2009/470/EC. |
| --- | --- |

(8)

The commitment of the expenditure for those multiannual programmes was adopted in accordance with Article 76(3) of Council Regulation (EC, Euratom) No 1605/2002 of 25 June 2002 on the Financial Regulation applicable to the general budget of the European Communities (9). The first budget commitment for those programmes was made after their approval. Each subsequent annual commitment should be made by the Commission in function of the execution of the programme for the previous year, on the basis of a decision to grant a contribution referred to in Article 27(5) of Decision 2009/470/EC.

| (9) | Certain Member States which have been successfully implementing rabies eradication programmes that have been co-financed for several years, share land borders with third countries where that disease is present. In order to finally eradicate rabies, certain vaccination activities need to be carried out in the territory of those third countries adjacent to the Union. |
| --- | --- |

(9)

Certain Member States which have been successfully implementing rabies eradication programmes that have been co-financed for several years, share land borders with third countries where that disease is present. In order to finally eradicate rabies, certain vaccination activities need to be carried out in the territory of those third countries adjacent to the Union.

| (10) | In order to support the implementation of rabies vaccination activities to be carried out in the territory of those third countries adjacent to the Union, the payment of an advance of up to 60 % of the maximum amount set for such activities under the Member State programmes, should be made possible. |
| --- | --- |

(10)

In order to support the implementation of rabies vaccination activities to be carried out in the territory of those third countries adjacent to the Union, the payment of an advance of up to 60 % of the maximum amount set for such activities under the Member State programmes, should be made possible.

| (11) | The Commission has assessed the annual programmes submitted by the Member States, as well as the fifth, fourth, third and second years respectively of the multiannual programmes approved for 2008, 2009, 2010 and 2011, from both the veterinary and financial point of view. Those programmes comply with the relevant Union veterinary legislation and in particular with the criteria set out in Decision 2008/341/EC. |
| --- | --- |

(11)

The Commission has assessed the annual programmes submitted by the Member States, as well as the fifth, fourth, third and second years respectively of the multiannual programmes approved for 2008, 2009, 2010 and 2011, from both the veterinary and financial point of view. Those programmes comply with the relevant Union veterinary legislation and in particular with the criteria set out in Decision 2008/341/EC.

| (12) | In the light of the importance of the annual and multiannual programmes for the achievement of Union objectives in the field of animal and public health, as well as the obligatory application in all Member States in the case of the Transmissible spongiform encephalopathies (TSE) and avian influenza programmes, it is appropriate to fix the appropriate rate of the Union financial contribution to reimburse the costs to be incurred by the Member States concerned for the measures referred to in this Decision up to a maximum amount for each programme. |
| --- | --- |

(12)

In the light of the importance of the annual and multiannual programmes for the achievement of Union objectives in the field of animal and public health, as well as the obligatory application in all Member States in the case of the Transmissible spongiform encephalopathies (TSE) and avian influenza programmes, it is appropriate to fix the appropriate rate of the Union financial contribution to reimburse the costs to be incurred by the Member States concerned for the measures referred to in this Decision up to a maximum amount for each programme.

| (13) | In accordance with Article 75 of the Financial Regulation and Article 90(1) of the Implementing Rules, the commitment of expenditure from the Union budget shall be preceded by a financing Decision setting out the essential elements of the action involving expenditure and adopted by the institution or the authorities to which powers have been delegated by the institution. |
| --- | --- |

(13)

In accordance with Article 75 of the Financial Regulation and Article 90(1) of the Implementing Rules, the commitment of expenditure from the Union budget shall be preceded by a financing Decision setting out the essential elements of the action involving expenditure and adopted by the institution or the authorities to which powers have been delegated by the institution.

| (14) | Verification of individual justifications of eligible costs creates extensive administrative burdens while not notably increasing the efficient use of Union funds or transparency. It is thus more appropriate to fix the Union financial contribution, for each programme, where appropriate, at a level that ensures that costs entailed by the type of measure, if implemented are adequately covered. Union financial contribution supporting in particular defined activities such as sampling, testing and vaccination should accordingly be specified as lump sum intended to compensate for all costs normally incurred to perform the activity or to produce the respective test result. |
| --- | --- |

(14)

Verification of individual justifications of eligible costs creates extensive administrative burdens while not notably increasing the efficient use of Union funds or transparency. It is thus more appropriate to fix the Union financial contribution, for each programme, where appropriate, at a level that ensures that costs entailed by the type of measure, if implemented are adequately covered. Union financial contribution supporting in particular defined activities such as sampling, testing and vaccination should accordingly be specified as lump sum intended to compensate for all costs normally incurred to perform the activity or to produce the respective test result.

| (15) | Under Council Regulation (EC) No 1290/2005 of 21 June 2005 on the financing of the common agricultural policy (10), programmes for the eradication and control of animal diseases are to be financed under the European Agricultural Guarantee Fund. For financial control purposes, Articles 9, 36 and 37 of that Regulation are to apply. |
| --- | --- |

(15)

Under Council Regulation (EC) No 1290/2005 of 21 June 2005 on the financing of the common agricultural policy (10), programmes for the eradication and control of animal diseases are to be financed under the European Agricultural Guarantee Fund. For financial control purposes, Articles 9, 36 and 37 of that Regulation are to apply.

| (16) | The financial contribution from the Union should be granted subject to the condition that the actions planned are efficiently carried out and that the competent authorities supply all the necessary information within the time limits laid down in this Decision. |
| --- | --- |

(16)

The financial contribution from the Union should be granted subject to the condition that the actions planned are efficiently carried out and that the competent authorities supply all the necessary information within the time limits laid down in this Decision.

| (17) | For reasons of administrative efficiency all expenditure submitted for a financial contribution by the Union should be expressed in euro. In accordance with Regulation (EC) No 1290/2005, the conversion rate for expenditure in a currency other than the euro should be the most recent exchange rate set by the European Central Bank prior to the first day of the month in which the application is submitted by the Member State concerned. |
| --- | --- |

(17)

For reasons of administrative efficiency all expenditure submitted for a financial contribution by the Union should be expressed in euro. In accordance with Regulation (EC) No 1290/2005, the conversion rate for expenditure in a currency other than the euro should be the most recent exchange rate set by the European Central Bank prior to the first day of the month in which the application is submitted by the Member State concerned.

| (18) | The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health, |
| --- | --- |

(18)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

CHAPTER I

ANNUAL PROGRAMMES

Article 1

Bovine brucellosis

1.   The programmes for the eradication of bovine brucellosis submitted by Spain, Italy Portugal and the United Kingdom are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.   The financial contribution by the Union:

| (a) | shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:






  (i) | EUR 0,5 per domestic animal sampled; |
| --- | --- | --- |

(a)

shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled;

| (ii) | EUR 0,2 per rose bengal test; |
| --- | --- |

(ii)

EUR 0,2 per rose bengal test;

| (iii) | EUR 0,2 per SAT test; |
| --- | --- |

(iii)

EUR 0,2 per SAT test;

| (iv) | EUR 0,4 per complement fixation test; |
| --- | --- |

(iv)

EUR 0,4 per complement fixation test;

| (v) | EUR 0,5 per ELISA test; |
| --- | --- |

(v)

EUR 0,5 per ELISA test;

| (vi) | EUR 10 per bacteriological test; |
| --- | --- |

(vi)

EUR 10 per bacteriological test;

| (vii) | EUR 1 per domestic animal vaccinated; |
| --- | --- |

(vii)

EUR 1 per domestic animal vaccinated;

| (b) | shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes and shall on average not exceed EUR 375 per animal slaughtered; and |
| --- | --- |

(b)

shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes and shall on average not exceed EUR 375 per animal slaughtered; and

| (c) | shall not exceed the following:






  (i) | EUR 4 800 000 for Spain; |
| --- | --- | --- |

(c)

shall not exceed the following:

(i)

EUR 4 800 000 for Spain;

| (ii) | EUR 2 300 000 for Italy; |
| --- | --- |

(ii)

EUR 2 300 000 for Italy;

| (iii) | EUR 1 550 000 for Portugal; |
| --- | --- |

(iii)

EUR 1 550 000 for Portugal;

| (iv) | EUR 2 000 000 for the United Kingdom. |
| --- | --- |

(iv)

EUR 2 000 000 for the United Kingdom.

Article 2

Bovine tuberculosis

1.   The programmes for the eradication of bovine tuberculosis submitted by Ireland, Spain, Italy Portugal and the United Kingdom are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.   The financial contribution by the Union:

| (a) | shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:






  (i) | EUR 0,5 per domestic animal sampled; |
| --- | --- | --- |

(a)

shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled;

| (ii) | EUR 1,5 per tuberculin test; |
| --- | --- |

(ii)

EUR 1,5 per tuberculin test;

| (iii) | EUR 5 per gamma-interferon test; |
| --- | --- |

(iii)

EUR 5 per gamma-interferon test;

| (iv) | EUR 10 per bacteriological test; |
| --- | --- |

(iv)

EUR 10 per bacteriological test;

| (b) | shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes shall on average not exceed EUR 375 per animal slaughtered; and |
| --- | --- |

(b)

shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes shall on average not exceed EUR 375 per animal slaughtered; and

| (c) | shall not exceed the following:






  (i) | EUR 14 000 000 for Ireland; |
| --- | --- | --- |

(c)

shall not exceed the following:

(i)

EUR 14 000 000 for Ireland;

| (ii) | EUR 12 700 000 for Spain; |
| --- | --- |

(ii)

EUR 12 700 000 for Spain;

| (iii) | EUR 5 000 000 for Italy; |
| --- | --- |

(iii)

EUR 5 000 000 for Italy;

| (iv) | EUR 2 650 000 for Portugal; |
| --- | --- |

(iv)

EUR 2 650 000 for Portugal;

| (v) | EUR 31 200 000 for the United Kingdom. |
| --- | --- |

(v)

EUR 31 200 000 for the United Kingdom.

Article 3

Ovine and caprine brucellosis

1.   The programmes for the eradication of ovine and caprine brucellosis submitted by Greece, Italy, Spain, Cyprus, and Portugal are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.   The financial contribution by the Union:

| (a) | shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:






  (i) | EUR 0,5 per domestic animal sampled; |
| --- | --- | --- |

(a)

shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled;

| (ii) | EUR 0,2 per rose bengal test; |
| --- | --- |

(ii)

EUR 0,2 per rose bengal test;

| (iii) | EUR 0,4 per complement fixation test; |
| --- | --- |

(iii)

EUR 0,4 per complement fixation test;

| (iv) | EUR 10 per bacteriological test; |
| --- | --- |

(iv)

EUR 10 per bacteriological test;

| (v) | EUR 1 per domestic animal vaccinated; |
| --- | --- |

(v)

EUR 1 per domestic animal vaccinated;

| (b) | shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes and shall on average not exceed EUR 50 per animal slaughtered; and |
| --- | --- |

(b)

shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes and shall on average not exceed EUR 50 per animal slaughtered; and

| (c) | shall not exceed the following:






  (i) | EUR 2 050 000 for Greece; |
| --- | --- | --- |

(c)

shall not exceed the following:

(i)

EUR 2 050 000 for Greece;

| (ii) | EUR 8 700 000 for Spain; |
| --- | --- |

(ii)

EUR 8 700 000 for Spain;

| (iii) | EUR 3 700 000 for Italy; |
| --- | --- |

(iii)

EUR 3 700 000 for Italy;

| (iv) | EUR 190 000 for Cyprus; |
| --- | --- |

(iv)

EUR 190 000 for Cyprus;

| (v) | EUR 1 950 000 for Portugal. |
| --- | --- |

(v)

EUR 1 950 000 for Portugal.

Article 4

Bluetongue in endemic or high risk areas

1.   The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, the Czech Republic, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland and Sweden are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.   The financial contribution by the Union:

| (a) | shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:






  (i) | EUR 0,5 per domestic animal sampled; |
| --- | --- | --- |

(a)

shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled;

| (ii) | EUR 1 per domestic animal vaccinated; |
| --- | --- |

(ii)

EUR 1 per domestic animal vaccinated;

| (iii) | EUR 2 per ELISA test; |
| --- | --- |

(iii)

EUR 2 per ELISA test;

| (iv) | EUR 10 per PCR test; |
| --- | --- |

(iv)

EUR 10 per PCR test;

| (v) | EUR 10 per virological test; |
| --- | --- |

(v)

EUR 10 per virological test;

| (b) | shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for:






  (i) | the cost of carrying out laboratory tests for entomological surveillance; |
| --- | --- | --- |

(b)

shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for:

(i)

the cost of carrying out laboratory tests for entomological surveillance;

| (ii) | the purchase of traps; and |
| --- | --- |

(ii)

the purchase of traps; and

| (c) | shall not exceed the following:






  (i) | EUR 360 000 for Belgium; |
| --- | --- | --- |

(c)

shall not exceed the following:

(i)

EUR 360 000 for Belgium;

| (ii) | EUR 15 000 for Bulgaria; |
| --- | --- |

(ii)

EUR 15 000 for Bulgaria;

| (iii) | EUR 40 000 for the Czech Republic; |
| --- | --- |

(iii)

EUR 40 000 for the Czech Republic;

| (iv) | EUR 80 000 for Germany; |
| --- | --- |

(iv)

EUR 80 000 for Germany;

| (v) | EUR 10 000 for Estonia; |
| --- | --- |

(v)

EUR 10 000 for Estonia;

| (vi) | EUR 40 000 for Ireland; |
| --- | --- |

(vi)

EUR 40 000 for Ireland;

| (vii) | EUR 100 000 for Greece; |
| --- | --- |

(vii)

EUR 100 000 for Greece;

| (viii) | EUR 1 000 000 for Spain; |
| --- | --- |

(viii)

EUR 1 000 000 for Spain;

| (ix) | EUR 1 700 000 for France; |
| --- | --- |

(ix)

EUR 1 700 000 for France;

| (x) | EUR 400 000 for Italy; |
| --- | --- |

(x)

EUR 400 000 for Italy;

| (xi) | EUR 20 000 for Latvia; |
| --- | --- |

(xi)

EUR 20 000 for Latvia;

| (xii) | EUR 10 000 for Lithuania; |
| --- | --- |

(xii)

EUR 10 000 for Lithuania;

| (xiii) | EUR 10 000 for Luxembourg; |
| --- | --- |

(xiii)

EUR 10 000 for Luxembourg;

| (xiv) | EUR 30 000 for Hungary; |
| --- | --- |

(xiv)

EUR 30 000 for Hungary;

| (xv) | EUR 10 000 for Malta; |
| --- | --- |

(xv)

EUR 10 000 for Malta;

| (xvi) | EUR 40 000 for the Netherlands; |
| --- | --- |

(xvi)

EUR 40 000 for the Netherlands;

| (xvii) | EUR 10 000 for Austria; |
| --- | --- |

(xvii)

EUR 10 000 for Austria;

| (xviii) | EUR 50 000 for Poland; |
| --- | --- |

(xviii)

EUR 50 000 for Poland;

| (xix) | EUR 2 350 000 for Portugal; |
| --- | --- |

(xix)

EUR 2 350 000 for Portugal;

| (xx) | EUR 100 000 for Romania; |
| --- | --- |

(xx)

EUR 100 000 for Romania;

| (xxi) | EUR 40 000 for Slovenia; |
| --- | --- |

(xxi)

EUR 40 000 for Slovenia;

| (xxii) | EUR 50 000 for Slovakia; |
| --- | --- |

(xxii)

EUR 50 000 for Slovakia;

| (xxiii) | EUR 10 000 for Finland; |
| --- | --- |

(xxiii)

EUR 10 000 for Finland;

| (xxiv) | EUR 10 000 for Sweden. |
| --- | --- |

(xxiv)

EUR 10 000 for Sweden.

Article 5

Salmonellosis (zoonotic salmonella) in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo)

1.   The programmes for the control of certain zoonotic salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Luxembourg, Hungary, Malta, the Netherlands, Austria, Portugal, Romania, Slovenia Slovakia, and the United Kingdom are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.   The programmes for the control of certain zoonotic salmonella in broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by Poland is hereby approved for the period from 1 January 2012 to 31 December 2012.

3.   The financial contribution by the Union:

| (a) | shall include a lump sum of EUR 0,5 per official sample taken; |
| --- | --- |

(a)

shall include a lump sum of EUR 0,5 per official sample taken;

| (b) | shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 and 2 for the cost of:






  (i) | carrying out bacteriological and serotyping tests in the framework of official sampling; |
| --- | --- | --- |

(b)

shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 and 2 for the cost of:

(i)

carrying out bacteriological and serotyping tests in the framework of official sampling;

| (ii) | carrying out bacteriological tests to verify the efficiency of disinfection; |
| --- | --- |

(ii)

carrying out bacteriological tests to verify the efficiency of disinfection;

| (iii) | carrying out tests for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonella; |
| --- | --- |

(iii)

carrying out tests for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonella;

| (iv) | the purchase of vaccine doses; |
| --- | --- |

(iv)

the purchase of vaccine doses;

| (v) | the compensation to be paid to owners for the value of:






  — | the culled breeding and laying birds of Gallus gallus, |
| --- | --- | --- |

(v)

the compensation to be paid to owners for the value of:

—

the culled breeding and laying birds of Gallus gallus,

| — | the culled breeding turkey birds of Meleagris gallopavo, |
| --- | --- |

—

the culled breeding turkey birds of Meleagris gallopavo,

| — | the destroyed eggs as referred to in paragraph 4; and |
| --- | --- |

—

the destroyed eggs as referred to in paragraph 4; and

| (c) | shall not exceed the following:






  (i) | EUR 1 300 000 for Belgium; |
| --- | --- | --- |

(c)

shall not exceed the following:

(i)

EUR 1 300 000 for Belgium;

| (ii) | EUR 60 000 for Bulgaria; |
| --- | --- |

(ii)

EUR 60 000 for Bulgaria;

| (iii) | EUR 1 500 000 for the Czech Republic; |
| --- | --- |

(iii)

EUR 1 500 000 for the Czech Republic;

| (iv) | EUR 250 000 for Denmark; |
| --- | --- |

(iv)

EUR 250 000 for Denmark;

| (v) | EUR 1 000 000 for Germany; |
| --- | --- |

(v)

EUR 1 000 000 for Germany;

| (vi) | EUR 30 000 for Estonia; |
| --- | --- |

(vi)

EUR 30 000 for Estonia;

| (vii) | EUR 300 000 for Ireland; |
| --- | --- |

(vii)

EUR 300 000 for Ireland;

| (viii) | EUR 1 000 000 for Greece; |
| --- | --- |

(viii)

EUR 1 000 000 for Greece;

| (ix) | EUR 1 000 000 for Spain; |
| --- | --- |

(ix)

EUR 1 000 000 for Spain;

| (x) | EUR 1 300 000 for France; |
| --- | --- |

(x)

EUR 1 300 000 for France;

| (xi) | EUR 700 000 for Italy; |
| --- | --- |

(xi)

EUR 700 000 for Italy;

| (xii) | EUR 100 000 for Cyprus; |
| --- | --- |

(xii)

EUR 100 000 for Cyprus;

| (xiii) | EUR 130 000 for Latvia; |
| --- | --- |

(xiii)

EUR 130 000 for Latvia;

| (xiv) | EUR 10 000 for Luxembourg; |
| --- | --- |

(xiv)

EUR 10 000 for Luxembourg;

| (xv) | EUR 2 000 000 for Hungary; |
| --- | --- |

(xv)

EUR 2 000 000 for Hungary;

| (xvi) | EUR 150 000 for Malta; |
| --- | --- |

(xvi)

EUR 150 000 for Malta;

| (xvii) | EUR 3 000 000 for the Netherlands; |
| --- | --- |

(xvii)

EUR 3 000 000 for the Netherlands;

| (xviii) | EUR 800 000 for Austria; |
| --- | --- |

(xviii)

EUR 800 000 for Austria;

| (xix) | EUR 500 000 for Poland; |
| --- | --- |

(xix)

EUR 500 000 for Poland;

| (xx) | EUR 200 000 for Portugal; |
| --- | --- |

(xx)

EUR 200 000 for Portugal;

| (xxi) | EUR 200 000 for Romania; |
| --- | --- |

(xxi)

EUR 200 000 for Romania;

| (xxii) | EUR 70 000 for Slovenia; |
| --- | --- |

(xxii)

EUR 70 000 for Slovenia;

| (xxiii) | EUR 600 000 for Slovakia; |
| --- | --- |

(xxiii)

EUR 600 000 for Slovakia;

| (xxiv) | EUR 75 000 for the United Kingdom. |
| --- | --- |

(xxiv)

EUR 75 000 for the United Kingdom.

4.   The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraphs 1 and 2 shall on average not exceed:

| (a) | for a bacteriological test (cultivation/isolation): | EUR 7 per test; |
| --- | --- | --- |
| (b) | for the purchase of vaccine: | EUR 0,05 per dose; |
| (c) | for serotyping of relevant isolates of salmonella spp.: | EUR 20 per test; |
| (d) | for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a salmonella-positive flock: | EUR 5 per test; |
| (e) | for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonella: | EUR 5 per test; |
| (f) | for the compensation to be paid to owners for the value of: | |
| | (i) | a parent breeding bird of Gallus gallus culled: | EUR 4 per bird; |
| | (ii) | a commercial laying bird of Gallus gallus culled: | EUR 2,20 per bird; |
| | (iii) | a parent breeding turkey bird of Meleagris gallopavo culled: | EUR 12 per bird; |
| | (iv) | hatching eggs of parent breeding Gallus gallus: | EUR 0,20 per hatching egg destroyed; |
| | (v) | table eggs of Gallus gallus: | EUR 0,04 per table egg destroyed; |
| | (vi) | hatching eggs of parent breeding Meleagris gallopavo: | EUR 0,40 per hatching egg destroyed. |

(a)

for a bacteriological test (cultivation/isolation):

EUR 7 per test;

(b)

for the purchase of vaccine:

EUR 0,05 per dose;

(c)

for serotyping of relevant isolates of salmonella spp.:

EUR 20 per test;

(d)

for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a salmonella-positive flock:

EUR 5 per test;

(e)

for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonella:

EUR 5 per test;

(f)

for the compensation to be paid to owners for the value of:

(i)

a parent breeding bird of Gallus gallus culled:

EUR 4 per bird;

(ii)

a commercial laying bird of Gallus gallus culled:

EUR 2,20 per bird;

(iii)

a parent breeding turkey bird of Meleagris gallopavo culled:

EUR 12 per bird;

(iv)

hatching eggs of parent breeding Gallus gallus:

EUR 0,20 per hatching egg destroyed;

(v)

table eggs of Gallus gallus:

EUR 0,04 per table egg destroyed;

(vi)

hatching eggs of parent breeding Meleagris gallopavo:

EUR 0,40 per hatching egg destroyed.

Article 6

Classical swine fever and African swine fever

1.   The programmes for the control and monitoring of:

| (a) | Classical swine fever submitted by Bulgaria, Germany, France, Luxembourg, Hungary, Romania, Slovenia and Slovakia are hereby approved for the period from 1 January 2012 to 31 December 2012; |
| --- | --- |

(a)

Classical swine fever submitted by Bulgaria, Germany, France, Luxembourg, Hungary, Romania, Slovenia and Slovakia are hereby approved for the period from 1 January 2012 to 31 December 2012;

| (b) | African swine fever submitted by Italy is hereby approved for the period from 1 January 2012 to 31 December 2012. |
| --- | --- |

(b)

African swine fever submitted by Italy is hereby approved for the period from 1 January 2012 to 31 December 2012.

2.   The financial contribution by the Union:

| (a) | shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:






  (i) | EUR 0,5 per domestic pig sampled; |
| --- | --- | --- |

(a)

shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic pig sampled;

| (ii) | EUR 5 per wild boar sampled; |
| --- | --- |

(ii)

EUR 5 per wild boar sampled;

| (iii) | EUR 1 per bait/vaccine; |
| --- | --- |

(iii)

EUR 1 per bait/vaccine;

| (iv) | EUR 2 per ELISA test; |
| --- | --- |

(iv)

EUR 2 per ELISA test;

| (v) | EUR 10 per PCR test; |
| --- | --- |

(v)

EUR 10 per PCR test;

| (vi) | EUR 10 per virological test; |
| --- | --- |

(vi)

EUR 10 per virological test;

| (b) | shall not exceed the following:






  (i) | EUR 210 000 for Bulgaria; |
| --- | --- | --- |

(b)

shall not exceed the following:

(i)

EUR 210 000 for Bulgaria;

| (ii) | EUR 1 300 000 for Germany; |
| --- | --- |

(ii)

EUR 1 300 000 for Germany;

| (iii) | EUR 260 000 for France; |
| --- | --- |

(iii)

EUR 260 000 for France;

| (iv) | EUR 100 000 for Italy; |
| --- | --- |

(iv)

EUR 100 000 for Italy;

| (v) | EUR 10 000 for Luxembourg; |
| --- | --- |

(v)

EUR 10 000 for Luxembourg;

| (vi) | EUR 340 000 for Hungary; |
| --- | --- |

(vi)

EUR 340 000 for Hungary;

| (vii) | EUR 900 000 for Romania; |
| --- | --- |

(vii)

EUR 900 000 for Romania;

| (viii) | EUR 30 000 for Slovenia; |
| --- | --- |

(viii)

EUR 30 000 for Slovenia;

| (ix) | EUR 500 000 for Slovakia. |
| --- | --- |

(ix)

EUR 500 000 for Slovakia.

Article 7

Swine vesicular disease

1.   The programme for the eradication of swine vesicular disease submitted by Italy is hereby approved for the period from 1 January 2012 to 31 December 2012.

2.   The financial contribution by the Union:

| (a) | shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:






  (i) | EUR 0,5 per domestic pig sampled; |
| --- | --- | --- |

(a)

shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic pig sampled;

| (ii) | EUR 2 per ELISA test; |
| --- | --- |

(ii)

EUR 2 per ELISA test;

| (iii) | EUR 4 per seroneutralisation test; |
| --- | --- |

(iii)

EUR 4 per seroneutralisation test;

| (iv) | EUR 10 per PCR test; |
| --- | --- |

(iv)

EUR 10 per PCR test;

| (v) | EUR 10 per virological test; |
| --- | --- |

(v)

EUR 10 per virological test;

| (b) | shall not exceed EUR 900 000. |
| --- | --- |

(b)

shall not exceed EUR 900 000.

Article 8

Avian influenza in poultry and wild birds

1.   The survey programmes for avian influenza in poultry and wild birds submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden and the United Kingdom are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.   The financial contribution by the Union:

| (a) | shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:






  (i) | EUR 0,5 per sample from poultry flocks; |
| --- | --- | --- |

(a)

shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per sample from poultry flocks;

| (ii) | EUR 5 per wild bird sampled in the framework of the passive surveillance; |
| --- | --- |

(ii)

EUR 5 per wild bird sampled in the framework of the passive surveillance;

| (iii) | EUR 1 per ELISA test; |
| --- | --- |

(iii)

EUR 1 per ELISA test;

| (iv) | EUR 1 per agar gel immune diffusion test; |
| --- | --- |

(iv)

EUR 1 per agar gel immune diffusion test;

| (b) | shall be at the rate of 50 % of the costs to be incurred by each Member State for the costs of carrying out laboratory tests other than those foreseen in point (a); and |
| --- | --- |

(b)

shall be at the rate of 50 % of the costs to be incurred by each Member State for the costs of carrying out laboratory tests other than those foreseen in point (a); and

| (c) | shall not exceed the following:






  (i) | EUR 40 000 for Belgium; |
| --- | --- | --- |

(c)

shall not exceed the following:

(i)

EUR 40 000 for Belgium;

| (ii) | EUR 40 000 for Bulgaria; |
| --- | --- |

(ii)

EUR 40 000 for Bulgaria;

| (iii) | EUR 30 000 for the Czech Republic; |
| --- | --- |

(iii)

EUR 30 000 for the Czech Republic;

| (iv) | EUR 40 000 for Denmark; |
| --- | --- |

(iv)

EUR 40 000 for Denmark;

| (v) | EUR 80 000 for Germany; |
| --- | --- |

(v)

EUR 80 000 for Germany;

| (vi) | EUR 10 000 for Estonia; |
| --- | --- |

(vi)

EUR 10 000 for Estonia;

| (vii) | EUR 60 000 for Ireland; |
| --- | --- |

(vii)

EUR 60 000 for Ireland;

| (viii) | EUR 10 000 for Greece; |
| --- | --- |

(viii)

EUR 10 000 for Greece;

| (ix) | EUR 90 000 for Spain; |
| --- | --- |

(ix)

EUR 90 000 for Spain;

| (x) | EUR 130 000 for France; |
| --- | --- |

(x)

EUR 130 000 for France;

| (xi) | EUR 800 000 for Italy; |
| --- | --- |

(xi)

EUR 800 000 for Italy;

| (xii) | EUR 10 000 for Cyprus; |
| --- | --- |

(xii)

EUR 10 000 for Cyprus;

| (xiii) | EUR 20 000 for Latvia; |
| --- | --- |

(xiii)

EUR 20 000 for Latvia;

| (xiv) | EUR 10 000 for Lithuania; |
| --- | --- |

(xiv)

EUR 10 000 for Lithuania;

| (xv) | EUR 10 000 for Luxembourg; |
| --- | --- |

(xv)

EUR 10 000 for Luxembourg;

| (xvi) | EUR 130 000 for Hungary; |
| --- | --- |

(xvi)

EUR 130 000 for Hungary;

| (xvii) | EUR 10 000 for Malta; |
| --- | --- |

(xvii)

EUR 10 000 for Malta;

| (xviii) | EUR 190 000 for the Netherlands; |
| --- | --- |

(xviii)

EUR 190 000 for the Netherlands;

| (xix) | EUR 50 000 for Austria; |
| --- | --- |

(xix)

EUR 50 000 for Austria;

| (xx) | EUR 100 000 for Poland; |
| --- | --- |

(xx)

EUR 100 000 for Poland;

| (xxi) | EUR 20 000 for Portugal; |
| --- | --- |

(xxi)

EUR 20 000 for Portugal;

| (xxii) | EUR 250 000 for Romania; |
| --- | --- |

(xxii)

EUR 250 000 for Romania;

| (xxiii) | EUR 30 000 for Slovenia; |
| --- | --- |

(xxiii)

EUR 30 000 for Slovenia;

| (xxiv) | EUR 20 000 for Slovakia; |
| --- | --- |

(xxiv)

EUR 20 000 for Slovakia;

| (xxv) | EUR 10 000 for Finland; |
| --- | --- |

(xxv)

EUR 10 000 for Finland;

| (xxvi) | EUR 40 000 for Sweden; |
| --- | --- |

(xxvi)

EUR 40 000 for Sweden;

| (xxvii) | EUR 100 000 for the United Kingdom. |
| --- | --- |

(xxvii)

EUR 100 000 for the United Kingdom.

3.   The maximum of the costs to be reimbursed to the Member States for the tests covered by the programmes shall on average not exceed:

| (a) | HI test for H5/H7: | EUR 12 per test; |
| --- | --- | --- |
| (b) | virus isolation test: | EUR 40 per test; |
| (c) | PCR test: | EUR 20 per test. |

(a)

HI test for H5/H7:

EUR 12 per test;

(b)

virus isolation test:

EUR 40 per test;

(c)

PCR test:

EUR 20 per test.

Article 9

Transmissible spongiform encephalopathies (TSE), bovine spongiform encephalopathy (BSE) and scrapie

1.   The programmes for the monitoring of transmissible spongiform encephalopathies (TSE), and for the eradication of bovine spongiform encephalopathy (BSE) and of scrapie submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, and the United Kingdom are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.   The financial contribution by the Union:

| (a) | shall consist of a lump sum of:






  (i) | EUR 8,5 per test, compensating for all costs incurred to perform rapid tests, to fulfil the requirements of Article 12 paragraph 2 and Annex III Chapter A Part I to Regulation (EC) No 999/2001 or used as confirmatory tests in accordance with Annex X, Chapter C to the same Regulation; |
| --- | --- | --- |

(a)

shall consist of a lump sum of:

(i)

EUR 8,5 per test, compensating for all costs incurred to perform rapid tests, to fulfil the requirements of Article 12 paragraph 2 and Annex III Chapter A Part I to Regulation (EC) No 999/2001 or used as confirmatory tests in accordance with Annex X, Chapter C to the same Regulation;

| (ii) | EUR 15 per test, compensating for all costs incurred to perform rapid tests to fulfil the requirements of Article 12 paragraph 2, Annex III Chapter A Part II points 1 to 5 and Annex VII to Regulation (EC) No 999/2001; |
| --- | --- |

(ii)

EUR 15 per test, compensating for all costs incurred to perform rapid tests to fulfil the requirements of Article 12 paragraph 2, Annex III Chapter A Part II points 1 to 5 and Annex VII to Regulation (EC) No 999/2001;

| (iii) | EUR 4 per test, compensating for all costs incurred to perform genotyping tests; |
| --- | --- |

(iii)

EUR 4 per test, compensating for all costs incurred to perform genotyping tests;

| (iv) | EUR 120 per test, compensating for all costs incurred to perform primary molecular discriminatory tests as referred to in point 3.2(c)(i) of Chapter C of Annex X to Regulation (EC) No 999/2001; and |
| --- | --- |

(iv)

EUR 120 per test, compensating for all costs incurred to perform primary molecular discriminatory tests as referred to in point 3.2(c)(i) of Chapter C of Annex X to Regulation (EC) No 999/2001; and

| (v) | EUR 25 per test, compensating for all costs incurred to perform confirmatory tests, other than rapid tests, as referred to in Annex X Chapter C to Regulation (EC) No 999/2001; |
| --- | --- |

(v)

EUR 25 per test, compensating for all costs incurred to perform confirmatory tests, other than rapid tests, as referred to in Annex X Chapter C to Regulation (EC) No 999/2001;

| (b) | shall be at the rate of 50 % of the cost incurred by each Member State for the compensation to be paid to owners for the value of their animals culled and destroyed in accordance with their BSE and scrapie eradication programmes; |
| --- | --- |

(b)

shall be at the rate of 50 % of the cost incurred by each Member State for the compensation to be paid to owners for the value of their animals culled and destroyed in accordance with their BSE and scrapie eradication programmes;

| (c) | shall not exceed the following:






  (i) | EUR 1 220 000 for Belgium; |
| --- | --- | --- |

(c)

shall not exceed the following:

(i)

EUR 1 220 000 for Belgium;

| (ii) | EUR 500 000 for Bulgaria; |
| --- | --- |

(ii)

EUR 500 000 for Bulgaria;

| (iii) | EUR 590 000 for the Czech Republic; |
| --- | --- |

(iii)

EUR 590 000 for the Czech Republic;

| (iv) | EUR 730 000 for Denmark; |
| --- | --- |

(iv)

EUR 730 000 for Denmark;

| (v) | EUR 7 690 000 for Germany; |
| --- | --- |

(v)

EUR 7 690 000 for Germany;

| (vi) | EUR 120 000 for Estonia; |
| --- | --- |

(vi)

EUR 120 000 for Estonia;

| (vii) | EUR 2 890 000 for Ireland; |
| --- | --- |

(vii)

EUR 2 890 000 for Ireland;

| (viii) | EUR 1 540 000 for Greece; |
| --- | --- |

(viii)

EUR 1 540 000 for Greece;

| (ix) | EUR 4 320 000 for Spain; |
| --- | --- |

(ix)

EUR 4 320 000 for Spain;

| (x) | EUR 12 310 000 for France; |
| --- | --- |

(x)

EUR 12 310 000 for France;

| (xi) | EUR 4 160 000 for Italy; |
| --- | --- |

(xi)

EUR 4 160 000 for Italy;

| (xii) | EUR 1 910 000 for Cyprus; |
| --- | --- |

(xii)

EUR 1 910 000 for Cyprus;

| (xiii) | EUR 220 000 for Latvia; |
| --- | --- |

(xiii)

EUR 220 000 for Latvia;

| (xiv) | EUR 420 000 for Lithuania; |
| --- | --- |

(xiv)

EUR 420 000 for Lithuania;

| (xv) | EUR 80 000 for Luxembourg; |
| --- | --- |

(xv)

EUR 80 000 for Luxembourg;

| (xvi) | EUR 1 000 000 for Hungary; |
| --- | --- |

(xvi)

EUR 1 000 000 for Hungary;

| (xvii) | EUR 20 000 for Malta; |
| --- | --- |

(xvii)

EUR 20 000 for Malta;

| (xviii) | EUR 2 080 000 for the Netherlands; |
| --- | --- |

(xviii)

EUR 2 080 000 for the Netherlands;

| (xix) | EUR 1 410 000 for Austria; |
| --- | --- |

(xix)

EUR 1 410 000 for Austria;

| (xx) | EUR 2 690 000 for Poland; |
| --- | --- |

(xx)

EUR 2 690 000 for Poland;

| (xxi) | EUR 970 000 for Portugal; |
| --- | --- |

(xxi)

EUR 970 000 for Portugal;

| (xxii) | EUR 930 000 for Romania; |
| --- | --- |

(xxii)

EUR 930 000 for Romania;

| (xxiii) | EUR 210 000 for Slovenia; |
| --- | --- |

(xxiii)

EUR 210 000 for Slovenia;

| (xxiv) | EUR 380 000 for Slovakia; |
| --- | --- |

(xxiv)

EUR 380 000 for Slovakia;

| (xxv) | EUR 350 000 for Finland; |
| --- | --- |

(xxv)

EUR 350 000 for Finland;

| (xxvi) | EUR 500 000 for Sweden; |
| --- | --- |

(xxvi)

EUR 500 000 for Sweden;

| (xxvii) | EUR 5 000 000 for the United Kingdom. |
| --- | --- |

(xxvii)

EUR 5 000 000 for the United Kingdom.

3.   The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

| (a) | for culled and destroyed bovine animals: | EUR 500 per animal; |
| --- | --- | --- |
| (b) | for culled and destroyed sheep or goats: | EUR 70 per animal. |

(a)

for culled and destroyed bovine animals:

EUR 500 per animal;

(b)

for culled and destroyed sheep or goats:

EUR 70 per animal.

Article 10

Rabies

1.   The programmes for the eradication of rabies submitted by Bulgaria, Estonia, Hungary, Poland, Romania and Slovakia are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.   The financial contribution by the Union:

| (a) | shall include a lump sum of EUR 5 per wild animal sampled; |
| --- | --- |

(a)

shall include a lump sum of EUR 5 per wild animal sampled;

| (b) | shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of:






  (i) | carrying out laboratory tests for the detection of rabies antigen or antibodies; |
| --- | --- | --- |

(b)

shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of:

(i)

carrying out laboratory tests for the detection of rabies antigen or antibodies;

| (ii) | the isolation and characterisation of rabies virus; |
| --- | --- |

(ii)

the isolation and characterisation of rabies virus;

| (iii) | the detection of biomarker and the titration of vaccine baits; |
| --- | --- |

(iii)

the detection of biomarker and the titration of vaccine baits;

| (iv) | the purchase and distribution of oral vaccine plus baits; |
| --- | --- |

(iv)

the purchase and distribution of oral vaccine plus baits;

| (v) | the purchase and administration of parenteral vaccines to grazing animals; and |
| --- | --- |

(v)

the purchase and administration of parenteral vaccines to grazing animals; and

| (c) | shall not exceed the following:






  (i) | EUR 1 540 000 for Bulgaria; |
| --- | --- | --- |

(c)

shall not exceed the following:

(i)

EUR 1 540 000 for Bulgaria;

| (ii) | EUR 620 000 for Estonia; |
| --- | --- |

(ii)

EUR 620 000 for Estonia;

| (iii) | EUR 1 160 000 for Hungary; |
| --- | --- |

(iii)

EUR 1 160 000 for Hungary;

| (iv) | EUR 9 270 000 for Poland; |
| --- | --- |

(iv)

EUR 9 270 000 for Poland;

| (v) | EUR 4 000 000 for Romania; |
| --- | --- |

(v)

EUR 4 000 000 for Romania;

| (vi) | EUR 540 000 for Slovakia. |
| --- | --- |

(vi)

EUR 540 000 for Slovakia.

3.   The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

| (a) | for a serological test: | EUR 12 per test; |
| --- | --- | --- |
| (b) | for a test to detect tetracycline in bone: | EUR 12 per test; |
| (c) | for a fluorescent antibody test (FAT): | EUR 18 per test; |
| (d) | for the purchase of oral vaccine plus baits: | EUR 0,60 per dose; |
| (e) | for the distribution of oral vaccine plus baits: | EUR 0,35 per dose; |
| (f) | for the purchase of parenteral vaccine: | EUR 1 per dose; |
| (g) | for the administration of rabies vaccines to grazing animals: | EUR 1,50 per animal vaccinated, regardless of the number of doses used. |

(a)

for a serological test:

EUR 12 per test;

(b)

for a test to detect tetracycline in bone:

EUR 12 per test;

(c)

for a fluorescent antibody test (FAT):

EUR 18 per test;

(d)

for the purchase of oral vaccine plus baits:

EUR 0,60 per dose;

(e)

for the distribution of oral vaccine plus baits:

EUR 0,35 per dose;

(f)

for the purchase of parenteral vaccine:

EUR 1 per dose;

(g)

for the administration of rabies vaccines to grazing animals:

EUR 1,50 per animal vaccinated, regardless of the number of doses used.

4.   Notwithstanding paragraph 2 points (a) and (b) and paragraph 3, for the part of the Polish programme that will be implemented outside its territory, the financial contribution by the Union shall:

| (a) | be granted only for the costs of the purchase and of the distribution of oral vaccine plus baits; |
| --- | --- |

(a)

be granted only for the costs of the purchase and of the distribution of oral vaccine plus baits;

| (b) | be at the rate of 100 %; and |
| --- | --- |

(b)

be at the rate of 100 %; and

| (c) | not exceed EUR 1 260 000. |
| --- | --- |

(c)

not exceed EUR 1 260 000.

5.   The maximum of the costs to be reimbursed for the costs referred to in paragraph 4 shall on average not exceed for the purchase and the distribution of oral vaccine plus baits EUR 0,95 per dose.

CHAPTER II

MULTIANNUAL PROGRAMMES

Article 11

Rabies

1.   The multiannual programme for rabies submitted by Finland is hereby approved for the period from 1 January 2012 to 31 December 2014.

2.   The second year of the multiannual programmes for the eradication of rabies submitted by Italy and Latvia is hereby approved for the period from 1 January 2012 to 31 December 2012.

3.   The third year of the multiannual programmes for the eradication of rabies submitted by Lithuania and Austria is hereby approved for the period from 1 January 2012 to 31 December 2012.

4.   The fifth year of the multiannual programme for the eradication of rabies submitted by Slovenia is hereby approved for the period from 1 January 2012 to 31 December 2012.

5.   The financial contribution by the Union:

| (a) | shall include a lump sum of EUR 5 per wild animal sampled; |
| --- | --- |

(a)

shall include a lump sum of EUR 5 per wild animal sampled;

| (b) | shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 to 4 for the cost of:






  (i) | carrying out laboratory tests for the detection of rabies antigen or antibodies; |
| --- | --- | --- |

(b)

shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 to 4 for the cost of:

(i)

carrying out laboratory tests for the detection of rabies antigen or antibodies;

| (ii) | the isolation and characterisation of rabies virus; |
| --- | --- |

(ii)

the isolation and characterisation of rabies virus;

| (iii) | the detection of biomarker and the titration of vaccine baits; |
| --- | --- |

(iii)

the detection of biomarker and the titration of vaccine baits;

| (iv) | the purchase and distribution of oral vaccine plus baits; |
| --- | --- |

(iv)

the purchase and distribution of oral vaccine plus baits;

| (v) | the purchase and administration of parenteral vaccines to grazing animals; and |
| --- | --- |

(v)

the purchase and administration of parenteral vaccines to grazing animals; and

| (c) | shall not exceed the following for the year 2012:






  (i) | EUR 1 600 000 for Italy; |
| --- | --- | --- |

(c)

shall not exceed the following for the year 2012:

(i)

EUR 1 600 000 for Italy;

| (ii) | EUR 1 700 000 for Latvia; |
| --- | --- |

(ii)

EUR 1 700 000 for Latvia;

| (iii) | EUR 2 900 000 for Lithuania; |
| --- | --- |

(iii)

EUR 2 900 000 for Lithuania;

| (iv) | EUR 190 000 for Austria; |
| --- | --- |

(iv)

EUR 190 000 for Austria;

| (v) | EUR 810 000 for Slovenia; |
| --- | --- |

(v)

EUR 810 000 for Slovenia;

| (vi) | EUR 360 000 for Finland. |
| --- | --- |

(vi)

EUR 360 000 for Finland.

6.   The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

| (a) | for a serological test: | EUR 12 per test; |
| --- | --- | --- |
| (b) | for a test to detect tetracycline in bone: | EUR 12 per test; |
| (c) | for a fluorescent antibody test (FAT): | EUR 18 per test; |
| (d) | for the purchase of oral vaccine plus baits: | EUR 0,60 per dose; |
| (e) | for the distribution of oral vaccine plus baits: | EUR 0,35 per dose; |
| (f) | for the purchase of parenteral vaccine: | EUR 1 per dose; |
| (g) | for the administration of rabies vaccines to grazing animals: | EUR 1,50 per animal vaccinated, regardless of the number of doses used. |

(a)

for a serological test:

EUR 12 per test;

(b)

for a test to detect tetracycline in bone:

EUR 12 per test;

(c)

for a fluorescent antibody test (FAT):

EUR 18 per test;

(d)

for the purchase of oral vaccine plus baits:

EUR 0,60 per dose;

(e)

for the distribution of oral vaccine plus baits:

EUR 0,35 per dose;

(f)

for the purchase of parenteral vaccine:

EUR 1 per dose;

(g)

for the administration of rabies vaccines to grazing animals:

EUR 1,50 per animal vaccinated, regardless of the number of doses used.

7.   Notwithstanding paragraph 5 points (a) and (b) and paragraph 6, for the parts of the Latvian, Lithuanian and Finnish multiannual programmes that will be implemented outside these Member States’ territories, the financial contribution by the Union shall:

| (a) | be granted only for the costs for the purchase and the distribution of oral vaccine plus baits; |
| --- | --- |

(a)

be granted only for the costs for the purchase and the distribution of oral vaccine plus baits;

| (b) | be at the rate of 100 %; and |
| --- | --- |

(b)

be at the rate of 100 %; and

| (c) | not exceed for the year 2012:






  (i) | EUR 520 000 for Latvia; |
| --- | --- | --- |

(c)

not exceed for the year 2012:

(i)

EUR 520 000 for Latvia;

| (ii) | EUR 1 260 000 for Lithuania; |
| --- | --- |

(ii)

EUR 1 260 000 for Lithuania;

| (iii) | EUR 80 000 for Finland. |
| --- | --- |

(iii)

EUR 80 000 for Finland.

8.   The maximum of the costs to be reimbursed for the costs referred to in paragraph 7 shall on average not exceed for the purchase and the distribution of oral vaccine plus baits EUR 0,95 per dose.

Article 12

Salmonellosis (zoonotic salmonella) in breeding and in laying flocks of Gallus gallus

1.   The multiannual programmes for Salmonellosis (zoonotic salmonella) in breeding and in laying flocks of Gallus gallus submitted by Poland is hereby approved for the period from 1 January 2012 to 31 December 2013.

2.   The financial contribution by the Union:

| (a) | shall include a lump sum of EUR 0,5 per official sample taken; |
| --- | --- |

(a)

shall include a lump sum of EUR 0,5 per official sample taken;

| (b) | shall be at the rate of 50 % of the costs to be incurred by Poland referred to in paragraph 1 for the cost of the same measures as in paragraph 3 of Article 5. |
| --- | --- |

(b)

shall be at the rate of 50 % of the costs to be incurred by Poland referred to in paragraph 1 for the cost of the same measures as in paragraph 3 of Article 5.

The maximum financial contribution for the measures set out in Article 5 by the Union shall not exceed EUR 2 500 000 for 2012.

3.   The maximum of the costs to be reimbursed to Poland for the programmes referred to in paragraph 1 shall not exceed those set out in paragraph 4 of Article 5.

CHAPTER III

Article 13

Eligible expenditure

1.   Without prejudice to the upper limits of the financial contribution by the Union provided for in Articles 1 to 12, the eligible expenditure covered by the measures referred to in those Articles shall be limited to the expenditure set out in the Annex.

2.   Only costs incurred in the carrying out of the annual or multiannual programmes referred to in Articles 1 to 12 and paid before the submission of the final report by the Member States shall be eligible for co-financing by means of a financial contribution by the Union.

3.   In order to receive the lump sum fixed in Articles 1 to 12 in its entirety Member States shall confirm that they paid all costs incurred in the performance of the activity or test and that none of the costs have been borne by a third party, other than a Competent Authority. If part of the costs has been borne by a third party, Member States shall indicate the percentage or proportion of the total costs borne by that third party. The lump sum paid shall be reduced accordingly.

4.   Notwithstanding the provisions of paragraph 2, for the costs referred to in Articles 10(4) and 11(7), the Commission, upon the request of the concerned Member State, shall pay an advance of up to 60 % of the specified maximum amount within the three months following the receipt of the request.

CHAPTER IV

GENERAL AND FINAL PROVISIONS

Article 14

1.   The compensation to be paid to owners for the value of the animals culled or slaughtered and of the destroyed products shall be granted within 90 days from the date of:

| (a) | the slaughter or culling of the animal; |
| --- | --- |

(a)

the slaughter or culling of the animal;

| (b) | the destruction of the products; or |
| --- | --- |

(b)

the destruction of the products; or

| (c) | the presentation of the completed claim by the owner. |
| --- | --- |

(c)

the presentation of the completed claim by the owner.

2.   Article 9(1), (2) and (3) of Commission Regulation (EC) No 883/2006 (11) shall apply to compensation payments made after the period 90 days referred to in paragraph 1 of this Article.

Article 15

1.   The expenditure submitted by the Member States for a financial contribution by the Union shall be expressed in euro and shall exclude value added tax and all other taxes.

2.   Where the expenditure of a Member State is in a currency other than the euro, the Member State concerned shall convert it into euro by applying the most recent exchange rate set by the European Central Bank prior to the first day of the month in which the application is submitted by the Member State.

Article 16

1.   The financial contribution by the Union for the annual and multiannual programmes referred to in Articles 1 to 12 (‘the programmes’) shall be granted provided that the Member States concerned:

| (a) | implement the programmes in accordance with the relevant provisions of Union law, including rules on competition and on the award of public contracts; |
| --- | --- |

(a)

implement the programmes in accordance with the relevant provisions of Union law, including rules on competition and on the award of public contracts;

| (b) | bring into force by 1 January 2012 at the latest the laws, regulations and administrative provisions necessary for implementing the programmes; |
| --- | --- |

(b)

bring into force by 1 January 2012 at the latest the laws, regulations and administrative provisions necessary for implementing the programmes;

| (c) | forward to the Commission by 31 July 2012 at the latest, the intermediate technical and financial reports for the programmes, in accordance with Article 27(7)(a) of Decision 2009/470/EC, covering the period from 1 January 2012 to 30 June 2012; |
| --- | --- |

(c)

forward to the Commission by 31 July 2012 at the latest, the intermediate technical and financial reports for the programmes, in accordance with Article 27(7)(a) of Decision 2009/470/EC, covering the period from 1 January 2012 to 30 June 2012;

| (d) | only for the programmes referred to in Article 8, report to the Commission the positive and negative results of investigations detected during their surveillance of poultry and wild birds through the Commission online system, every six months, in accordance with Article 4 of Commission Decision 2010/367/EU (12); |
| --- | --- |

(d)

only for the programmes referred to in Article 8, report to the Commission the positive and negative results of investigations detected during their surveillance of poultry and wild birds through the Commission online system, every six months, in accordance with Article 4 of Commission Decision 2010/367/EU (12);

| (e) | forward an annual detailed technical report to the Commission for the programmes in accordance with Article 27(7)(b) of Decision 2009/470/EC by 30 April 2013 at the latest on the technical execution of the programme concerned accompanied by justifying evidence as to the costs paid by the Member State and the results attained during the period from 1 January 2012 to 31 December 2012; |
| --- | --- |

(e)

forward an annual detailed technical report to the Commission for the programmes in accordance with Article 27(7)(b) of Decision 2009/470/EC by 30 April 2013 at the latest on the technical execution of the programme concerned accompanied by justifying evidence as to the costs paid by the Member State and the results attained during the period from 1 January 2012 to 31 December 2012;

| (f) | implement the programmes efficiently; |
| --- | --- |

(f)

implement the programmes efficiently;

| (g) | do not submit further requests for other contributions from the Union for those measures, and have not previously submitted such requests. |
| --- | --- |

(g)

do not submit further requests for other contributions from the Union for those measures, and have not previously submitted such requests.

2.   Where a Member State does not comply with paragraph 1, the Commission may reduce the financial contribution by the Union having regard to the nature and gravity of the infringement, and to the financial loss for the Union.

Article 17

This decision constitutes a financing decision in the meaning of Article 75 of the Financial Regulation.

Article 18

This Decision shall apply from 1 January 2012.

Article 19

This Decision is addressed to the Member States.

Done at Brussels, 30 November 2011.

For the Commission

John DALLI

Member of the Commission

---

(1)  
  OJ L 155, 18.6.2009, p. 30.

1

(2)  
  OJ L 115, 29.4.2008, p. 44.

2

(3)  
  OJ L 147, 31.5.2001, p. 1.

3

(4)  
  OJ L 10, 14.1.2006, p. 16.

4

(5)  
  OJ L 314, 1.12.2007, p. 29.

5

(6)  
  OJ L 322, 2.12.2008, p. 39.

6

(7)  
  OJ L 317, 3.12.2009, p. 36.

7

(8)  
  OJ L 309, 25.11.2010, p. 18.

8

(9)  
  OJ L 248, 16.9.2002, p. 1.

9

(10)  
  OJ L 209, 11.8.2005, p. 1.

10

(11)  
  OJ L 171, 23.6.2006, p. 1.

11

(12)  
  OJ L 166, 1.7.2010, p. 22.

12

---

ANNEX

ELIGIBLE EXPENDITURE REFERRED TO IN ARTICLE 13(1)

The expenditure eligible for a financial contribution by the Union for the measures referred to in Articles 1 to 12 and not covered by a lump sum, shall be limited to the costs incurred by the Member States for the measures set out in points 1 to 8.

| 1. | Carrying out laboratory tests:






  (a) | the purchase of test kits, reagents and all consumables identifiable and especially used for carrying out the laboratory test; |
| --- | --- | --- |

1.

Carrying out laboratory tests:

(a)

the purchase of test kits, reagents and all consumables identifiable and especially used for carrying out the laboratory test;

| (b) | personnel, whatever the status, specifically allocated entirely or in part for carrying out the tests in the premises of the laboratory; the costs are limited to actual salaries plus social security charges and other statutory costs included in the remuneration); and |
| --- | --- |

(b)

personnel, whatever the status, specifically allocated entirely or in part for carrying out the tests in the premises of the laboratory; the costs are limited to actual salaries plus social security charges and other statutory costs included in the remuneration); and

| (c) | overheads equal to 7 % of the sum of the costs referred to in (a) and (b). |
| --- | --- |

(c)

overheads equal to 7 % of the sum of the costs referred to in (a) and (b).

| 2. | Compensation to owners for the value of their animals slaughtered or culled: | The compensation shall not exceed the market value of the animal immediately before it was slaughtered or culled. |
| --- | --- | --- |

2.

Compensation to owners for the value of their animals slaughtered or culled:

The compensation shall not exceed the market value of the animal immediately before it was slaughtered or culled.

| | For bovine brucellosis and tuberculosis and ovine and caprine brucellosis programmes, the salvage value, if any, shall be deducted from the compensation. |
| --- | --- |

For bovine brucellosis and tuberculosis and ovine and caprine brucellosis programmes, the salvage value, if any, shall be deducted from the compensation.

| 3. | Compensation to owners for the value of their birds culled and for destroyed eggs: | The compensation shall not exceed the market value of the bird immediately before it was culled or of the eggs immediately before their destruction. |
| --- | --- | --- |

3.

Compensation to owners for the value of their birds culled and for destroyed eggs:

The compensation shall not exceed the market value of the bird immediately before it was culled or of the eggs immediately before their destruction.

| | The salvage value for heat treated non-incubated eggs shall be deducted from the compensation. |
| --- | --- |

The salvage value for heat treated non-incubated eggs shall be deducted from the compensation.

| 4. | The purchase and storage of vaccine doses and/or vaccine plus baits for domestic and wild animals. |
| --- | --- |

4.

The purchase and storage of vaccine doses and/or vaccine plus baits for domestic and wild animals.

| 5. | The administration of vaccine doses to domestic animals:






  (a) | personnel, whatever the status, specifically allocated entirely or in part for carrying out the vaccination; the costs are limited to the fee paid for such personnel or to their actual salaries plus social security charges and other statutory costs included in the remuneration; and |
| --- | --- | --- |

5.

The administration of vaccine doses to domestic animals:

(a)

personnel, whatever the status, specifically allocated entirely or in part for carrying out the vaccination; the costs are limited to the fee paid for such personnel or to their actual salaries plus social security charges and other statutory costs included in the remuneration; and

| (b) | the specific equipment and consumables identifiable and used especially for the vaccination. |
| --- | --- |

(b)

the specific equipment and consumables identifiable and used especially for the vaccination.

| 6. | The distribution of vaccines plus baits for wild animals:






  (a) | the transport of the vaccines plus baits; |
| --- | --- | --- |

6.

The distribution of vaccines plus baits for wild animals:

(a)

the transport of the vaccines plus baits;

| (b) | the costs for the aerial or manual distribution of the vaccines plus baits; |
| --- | --- |

(b)

the costs for the aerial or manual distribution of the vaccines plus baits;

| (c) | personnel, whatever the status, specifically allocated entirely or in part for distributing vaccine baits; the costs are limited to their actual salaries plus social security charges and other statutory costs included in the remuneration. |
| --- | --- |

(c)

personnel, whatever the status, specifically allocated entirely or in part for distributing vaccine baits; the costs are limited to their actual salaries plus social security charges and other statutory costs included in the remuneration.

---